Literature DB >> 1981830

Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.

H C Maguire1, M I Greene.   

Abstract

The c-erbB-2 oncogene encodes a transmembrane phosphoglycoprotein. This molecule appears to be a growth factor receptor in the family of tyrosine kinase growth factor receptors; however, its ligand has not yet been identified. Amplification and/or overexpression of c-erbB-2 in breast adenocarcinomas occurs frequently and its occurrence implies a more advanced malignancy. This functional tumor marker is readily identified by appropriate DNA and antibody probes. The large external domain of the c-erbB-2 gene product is a promising target for immunodiagnostic and immunotherapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981830     DOI: 10.1159/000163601

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  8 in total

Review 1.  Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood.

Authors:  Jaclyn A Freudenberg; Kathryn Bembas; Mark I Greene; Hongtao Zhang
Journal:  Methods       Date:  2008-06-23       Impact factor: 3.608

2.  The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma.

Authors:  L M Shih; M Y Hsu; J P Palazzo; M Herlyn
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

3.  Establishment and characterization of new mammary adenocarcinoma cell lines derived from double transgenic mice expressing GFP and neu oncogene.

Authors:  M G Sacco; F Faggioli; S Soldati; L Gribaldo; A Collotta; F Pariselli; I Malerba; A Musio; C Montagna; E Mira Catò; P Vezzoni
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

4.  Proto-oncogene c-erbB2 initiates rat primordial follicle growth via PKC and MAPK pathways.

Authors:  Zheng Li-Ping; Zhang Da-Lei; Huang Jian; Xu Liang-Quan; Xu Ai-Xia; Du Xiao-Yu; Tang Dan-Feng; Zheng Yue-Hui
Journal:  Reprod Biol Endocrinol       Date:  2010-06-19       Impact factor: 5.211

Review 5.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

Review 6.  Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein.

Authors:  W C Dougall; M I Greene
Journal:  Cell Biophys       Date:  1994

7.  Structure based antibody-like peptidomimetics.

Authors:  Ramachandran Murali; Mark I Greene
Journal:  Pharmaceuticals (Basel)       Date:  2012-02-16

8.  Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.

Authors:  Alexander Schulz; Anna Kyselyova; Stephan L Baader; Marie Juliane Jung; Ansgar Zoch; Victor-Felix Mautner; Christian Hagel; Helen Morrison
Journal:  Brain       Date:  2013-12-05       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.